Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)Trade
IDEXX Laboratories, Inc.Trade

Price performance (Past 24H)

Key statistics

Haleon plc American Depositary Shares (Each representing two Ordinary Shares) vs IDEXX Laboratories, Inc. — how do they compare? Haleon plc American Depositary Shares (Each representing two Ordinary Shares) trades at $9.31 (market cap $40.01B), while IDEXX Laboratories, Inc. trades at $518.89 (market cap $40.43B). The key difference: Haleon plc American Depositary Shares (Each representing two Ordinary Shares) and IDEXX Laboratories, Inc. are close in size by market cap, and Haleon plc American Depositary Shares (Each representing two Ordinary Shares) pays a 2.14% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Haleon plc American Depositary Shares (Each representing two Ordinary Shares) for 1 Days and IDEXX Laboratories, Inc. for 46 Days on average.

HLNIDXX
Market Cap
$40.01B$40.43B
Volume
19,985,935692,164
Sector
HealthHealth
52-Week High
$11.27$766.68
52-Week Low
$8.70$504.70
Typical Hold Time
1 Days46 Days
Enterprise Value
$49.79B$41.32B
Dividend Yield
2.14%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

No Aura AI signal available yet.

IDEXX Laboratories, Inc.

IDEXX Laboratories (IDXX) trades at $519.87, up 2.61% on the day, with a bearish technical signal from moving averages but strong fundamentals including a 25.03% net income margin and consistent earnings beats. Revenue grew to $4.3B in 2025, and the company recently acquired CoVetAI to enhance veterinary workflow intelligence, signaling strategic expansion.

The stock's outlook is supported by robust profitability and analyst consensus, but faces headwinds from technical weakness and potential market volatility. With a $665 price target implying significant upside, the primary risks include competitive pressures and execution of growth initiatives amid economic uncertainties.

Returns comparison

Trailing returns across standard periods

About Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon is a consumer healthcare company offering over-the-counter medicines, oral health products, vitamins, and wellness brands.

Read more on HLN →

About IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.

Read more on IDXX →